Authors:
HOCK C
GOLOMBOWSKI S
MULLERSPAHN F
NASER W
BEYREUTHER K
MONNING U
SCHENK D
VIGOPELFREY C
BUSH AM
MOIR R
TANZI RE
GROWDON JH
NITSCH RM
Citation: C. Hock et al., CEREBROSPINAL-FLUID LEVELS OF AMYLOID PRECURSOR PROTEIN AND AMYLOID BETA-PEPTIDE IN ALZHEIMERS-DISEASE AND MAJOR DEPRESSION - INVERSE CORRELATION WITH DEMENTIA SEVERITY, European neurology, 39(2), 1998, pp. 111-118
Authors:
AKSENOV MY
AKSENOVA MV
BUTTERFIELD DA
HENSLEY K
VIGOPELFREY C
CARNEY JM
Citation: My. Aksenov et al., GLUTAMINE SYNTHETASE-INDUCED ENHANCEMENT OF BETA-AMYLOID PEPTIDE A-BETA(1-40) NEUROTOXICITY ACCOMPANIED BY ABROGATION OF FIBRIL FORMATION AND A-BETA FRAGMENTATION, Journal of neurochemistry, 66(5), 1996, pp. 2050-2056
Authors:
KUO YM
EMMERLING MR
VIGOPELFREY C
KASUNIC TC
KIRKPATRICK JB
MURDOCH GH
BALL MJ
ROHER AE
Citation: Ym. Kuo et al., WATER-SOLUBLE A-BETA (N-40, N-42) OLIGOMERS IN NORMAL AND ALZHEIMER-DISEASE BRAINS, The Journal of biological chemistry, 271(8), 1996, pp. 4077-4081
Authors:
MOTTER R
VIGOPELFREY C
KHOLODENKO D
BARBOUR R
JOHNSONWOOD K
GALASKO D
CHANG L
MILLER B
CLARK C
GREEN R
OLSON D
SOUTHWICK P
WOLFERT R
MUNROE B
LIEBERBURG I
SEUBERT P
SCHENK D
Citation: R. Motter et al., REDUCTION OF BETA-AMYLOID PEPTIDE(42), IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE, Annals of neurology, 38(4), 1995, pp. 643-648
Authors:
NITSCH RM
REBECK GW
DENG MH
RICHARDSON UI
TENNIS M
SCHENK DB
VIGOPELFREY C
LIEBERBURG I
WURTMAN RJ
HYMAN BT
GROWDON JH
Citation: Rm. Nitsch et al., CEREBROSPINAL-FLUID LEVELS OF AMYLOID BETA-PROTEIN IN ALZHEIMERS-DISEASE - INVERSE CORRELATION WITH SEVERITY OF DEMENTIA AND EFFECT OF APOLIPOPROTEIN-E GENOTYPE, Annals of neurology, 37(4), 1995, pp. 512-518
Authors:
LANNFELT L
BASUN H
VIGOPELFREY C
WAHLUND LO
WINBLAD B
LIEBERBURG I
SCHENK D
Citation: L. Lannfelt et al., AMYLOID BETA-PEPTIDE IN CEREBROSPINAL-FLUID IN INDIVIDUALS WITH THE SWEDISH ALZHEIMER AMYLOID PRECURSOR PROTEIN MUTATION, Neuroscience letters, 199(3), 1995, pp. 203-206
Authors:
WALLACE WC
LIEBERBURG I
SCHENK D
VIGOPELFREY C
DAVIS KL
HAROUTUNIAN V
Citation: Wc. Wallace et al., CHRONIC ELEVATION OF SECRETED AMYLOID PRECURSOR PROTEIN IN SUBCORTICALLY LESIONED RATS, AND ITS EXACERBATION IN AGED RATS, The Journal of neuroscience, 15(7), 1995, pp. 4896-4905
Authors:
VIGOPELFREY C
SEUBERT P
BARBOUR R
BLOMQUIST C
LEE M
LEE D
CORIA F
CHANG L
MILLER B
LIEBERBURG I
SCHENK D
Citation: C. Vigopelfrey et al., ELEVATION OF MICROTUBULE-ASSOCIATED PROTEIN TAN IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE, Neurology, 45(4), 1995, pp. 788-793
Authors:
JOHNSTON J
COWBURN R
WIEHAGER B
NORGREN S
LANNFELT L
VIGOPELFREY C
SCHENK D
CITRON M
SELKOE D
ONEILL C
Citation: J. Johnston et al., AMYLOID PRECURSOR PROTEIN EXPRESSION AND BETA-AMYLOID RELEASE IN FIBROBLAST CELL-LINES OBTAINED FROM FAMILY MEMBERS WITH THE SWEDISH APP670671 MUTATION/, Neurobiology of aging, 15, 1994, pp. 190000071-190000071
Authors:
LANNFELT L
BASUN H
WAHLUND LO
WINBLAD B
VIGOPELFREY C
SCHENK D
Citation: L. Lannfelt et al., DISEASE PROGRESSION CORRELATES WITH DECREASING CSF BETA-AMYLOID IN ALZHEIMER PATIENTS WITH THE SWEDISH APP-670 671 MUTATION/, Neurobiology of aging, 15, 1994, pp. 190000079-190000079
Authors:
VIGOPELFREY C
SEUBERT P
LEE M
LIEBERBURG I
LEE D
CORIA F
BARBOUR R
SCHENK D
Citation: C. Vigopelfrey et al., MEASUREMENT OF TAU IN HUMAN CSF AND ITS POSSIBLE UTILITY IN ALZHEIMERS-DISEASE DIAGNOSIS, Neurobiology of aging, 15, 1994, pp. 190000095-190000095
Authors:
SCHENK D
VIGOPELFREY C
LIEBERBURG I
BASUN H
WAHLUND LO
WINBLAD B
LANNFELT L
Citation: D. Schenk et al., INCREASED TAU LEVELS IN THE CEREBROSPINAL-FLUID IN CARRIERS OF THE SWEDISH 670 671-MUTATION IN THE AMYLOID PRECURSOR PROTEIN/, Neurobiology of aging, 15, 1994, pp. 190000146-190000146
Authors:
CITRON M
VIGOPELFREY C
TEPLOW DB
MILLER C
SCHENK D
JOHNSTON J
WINBLAD B
VENIZELOS N
LANNFELT L
SELKOE DJ
Citation: M. Citron et al., EXCESSIVE PRODUCTION OF AMYLOID BETA-PROTEIN BY PERIPHERAL CELLS OF SYMPTOMATIC AND PRESYMPTOMATIC PATIENTS CARRYING THE SWEDISH FAMILIAL ALZHEIMER-DISEASE MUTATION, Proceedings of the National Academy of Sciences of the United Statesof America, 91(25), 1994, pp. 11993-11997
Authors:
JOHNSTON JA
COWBURN RF
NORGREN S
WIEHAGER B
VENIZELOS N
WINBLAD B
VIGOPELFREY C
SCHENK D
LANNFELT L
ONEILL C
Citation: Ja. Johnston et al., INCREASED BETA-AMYLOID RELEASE AND LEVELS OF AMYLOID PRECURSOR PROTEIN (APP) IN FIBROBLAST CELL-LINES FROM FAMILY MEMBERS WITH THE SWEDISH ALZHEIMERS-DISEASE APP670 671 MUTATION/, FEBS letters, 354(3), 1994, pp. 274-278
Citation: Ss. Pierangeli et al., COMPARISON OF A FLUOROMETRIC TEST WITH THE STANDARD ELISA ASSAY FOR THE DETECTION OF ANTICARDIOLIPIN ANTIBODIES, Clinical and experimental rheumatology, 11(3), 1993, pp. 349-350
Authors:
VIGOPELFREY C
LEE D
KEIM P
LIEBERBURG I
SCHENK DB
Citation: C. Vigopelfrey et al., CHARACTERIZATION OF BETA-AMYLOID PEPTIDE FROM HUMAN CEREBROSPINAL-FLUID, Journal of neurochemistry, 61(5), 1993, pp. 1965-1968
Citation: Jk. Lang et C. Vigopelfrey, QUALITY-CONTROL OF LIPOSOMAL LIPIDS WITH SPECIAL EMPHASIS ON PEROXIDATION OF PHOSPHOLIPIDS AND CHOLESTEROL, Chemistry and physics of lipids, 64(1-3), 1993, pp. 19-29